Soligenix
SNGX
#10292
Rank
C$15.17 M
Marketcap
C$1.50
Share price
-0.90%
Change (1 day)
-56.43%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -C$17.45 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$12.79 Million a decrease over its 2023 earnings that were of -C$10.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$17.45 Million36.45%
2024 -C$12.79 Million22.96%
2023 -C$10.4 Million-45.74%
2022 -C$19.17 Million11.88%
2021 -C$17.13 Million-32.37%
2020 -C$25.33 Million83.18%
2019 -C$13.83 Million11.57%
2018 -C$12.4 Million19.29%
2017 -C$10.39 Million33%
2016 -C$7.81 Million-19.7%
2015 -C$9.73 Million5.16%
2014 -C$9.25 Million
2010 -C$10.44 Million26.12%
2009 -C$8.28 Million75.1%
2008 -C$4.73 Million-45.38%
2007 -C$8.66 Million-22.84%
2006 -C$11.22 Million66.15%
2005 -C$6.76 Million-16.65%
2004 -C$8.1 Million13.28%
2003 -C$7.15 Million-11.88%
2002 -C$8.12 Million-59.44%
2001 -C$20.01 Million378.18%
2000 -C$4.19 Million-38.53%
1999 -C$6.81 Million-18.43%
1998 -C$8.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.31 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.21 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.44 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$24.84 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.13 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.94 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.77 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA